Stay updated on Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    No significant changes were detected in the Study Details page for NCT03854474. The content and layout appear unchanged aside from routine metadata such as the last update timestamp.
    Difference
    0.3%
    Check dated 2025-11-03T00:56:59.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    2%
    Check dated 2025-10-05T09:10:09.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Updated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new release version.
    Difference
    0.0%
    Check dated 2025-09-28T03:03:20.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Updated to Revision: v3.0.2 (from v3.0.1); the 'Back to Top' element has been removed.
    Difference
    0.1%
    Check dated 2025-09-13T16:55:35.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new version and the addition of a Diagnostic CAT Scan service type, while previous update dates and version information have been removed.
    Difference
    0.6%
    Check dated 2025-09-06T14:27:09.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new medical terms related to bladder cancer and diagnostic techniques. Notably, the previous version's references to certain cancer treatments and genetic resources have been removed.
    Difference
    2%
    Check dated 2025-08-30T11:18:16.000Z thumbnail image

Stay in the know with updates to Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.